Plus Therapeutics Earnings Preview
Portfolio Pulse from Benzinga Insights
Plus Therapeutics (NASDAQ:PSTV) is set to release its quarterly earnings report on Monday, 2023-08-14, with analysts estimating an EPS of $-1.91. The company's past performance shows a trend of missing EPS estimates and subsequent drops in share price. The stock is currently trading at $3.16, down 69.55% over the last 52-week period.
August 11, 2023 | 5:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Plus Therapeutics is expected to report an EPS of $-1.91 in its upcoming earnings report. The company's history of missing EPS estimates and subsequent share price drops may impact investor sentiment.
Given Plus Therapeutics' history of missing EPS estimates and the subsequent negative impact on its share price, it is likely that the upcoming earnings report could have a negative impact on the stock, especially if the company fails to meet the EPS estimate again. The stock's poor performance over the past year also suggests a bearish sentiment among long-term shareholders.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100